HomeCBI • TLV
add
Clal Biotechnology Industries Ltd.
Previous close
ILA 46.40
Day range
ILA 44.50 - ILA 46.90
Year range
ILA 36.60 - ILA 65.00
Market cap
70.74M ILS
Avg Volume
131.91K
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
(ILS) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 16.00K | -68.00% |
Operating expense | 2.28M | -31.02% |
Net income | -16.74M | -171.46% |
Net profit margin | -104.61K | -748.30% |
Earnings per share | — | — |
EBITDA | 2.01M | 97.59% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(ILS) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 13.36M | 3.66% |
Total assets | 158.39M | -13.30% |
Total liabilities | 36.98M | -2.16% |
Total equity | 121.41M | — |
Shares outstanding | 156.85M | — |
Price to book | 0.74 | — |
Return on assets | -3.58% | — |
Return on capital | -3.61% | — |
Cash Flow
Net change in cash
(ILS) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -16.74M | -171.46% |
Cash from operations | -2.43M | 3.44% |
Cash from investing | 102.00K | -94.81% |
Cash from financing | -81.00K | 55.74% |
Net change in cash | -2.40M | -226.36% |
Free cash flow | -1.59M | 76.39% |
About
Founded
1998
Website
Employees
3